Dienstbier Z, Hermanská Z, Zámecník J, Melínová L, Vacková B, Skala E, Srbová D
I. interní klinika 1. LF UK, Praha.
Vnitr Lek. 1995 Dec;41(12):816-21.
From a group of 366 patients with complete data complete remission was achieved by 290. Fifty-five patients relapsed, 39 men and 16 women, mostly with an initial finding of advanced disease (KS III + IV 64%), with affection of the mediastinum (73%) aged under 40 years. 42% of the relapses were detected within one year after termination of primary treatment and 33% during the subsequent 2 years, the longest interval before a relapse being 20 years. During primary treatment in 63% of the patients chemotherapy was reduced to 75-25% of the total dose of cytostatics with protraction of the interval between cycles in 58% and radiotherapy in another 34% of the patients. 76% of the patients with a first relapse achieved a second complete remission and 29 of them survive without signs of the disease, 12 died from generalized lymphoma. Sixteen patients developed repeated relapses (nine two relapses, four three relapses, another two four relapses and one patient five relapses). After treatment of the relapse a total of 22 patients died, incl. 19 who died from Hodgkin's disease, two from secondary carcinoma and one from myocardial infarction. The longest survival period after treatment of a relapse was 26 years.
在366例有完整数据的患者中,290例实现了完全缓解。55例患者复发,其中男性39例,女性16例,大多数初诊时为晚期疾病(卡诺夫斯基评分III + IV级占64%),累及纵隔(占73%),年龄在40岁以下。42%的复发在初次治疗结束后1年内被发现,33%在随后2年内被发现,复发前最长间隔为20年。在初次治疗期间,63%的患者化疗剂量减至细胞毒性药物总剂量的75% - 25%,58%的患者周期间隔延长,另有34%的患者接受了放疗。76%首次复发的患者实现了第二次完全缓解,其中29例存活且无疾病迹象,12例死于全身性淋巴瘤。16例患者出现多次复发(9例复发2次,4例复发3次,另2例复发4次,1例患者复发5次)。复发治疗后共有22例患者死亡,其中19例死于霍奇金病,2例死于继发性癌症,1例死于心肌梗死。复发治疗后最长生存期为26年。